Cereno Scientific to present and engage in partnering and investor meetings at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announces that the company is attending the Biotech Showcase 2025 conference during J.P. Morgan Healthcare Week. CEO Sten R. Sörensen will hold a presentation at the conference, which takes place Januari 13-15 at the Hilton San Francisco Union Square, San Francisco.Sten R. Sörensen, CEO, will together with Rahul Agrawal, Chief Medical Officer and Head of R&D and Jeppe Øvlesen, Board Member, participate at the